Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.73 USD | +1.87% | +0.89% | +84.57% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+84.57% | 625M | - | ||
+13.25% | 2.91B | D+ | ||
+14.12% | 1.69B | - | ||
+3.64% | 485M | - | ||
+29.11% | 159M | - | ||
+13.51% | 108M | - | - | |
+52.81% | 56.96M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- GLASF Stock
- Ratings Glass House Brands Inc.